Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

267
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
267
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

735
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
735
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

90
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
90
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

79
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
79
Clinical Trials01:16

Clinical Trials

6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.8K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond data and technology: the need for new thinking to enable the era of precision prevention.

BMC medicine·2026
Same author

Current patient attitudes to artificial intelligence applications in radiology.

The British journal of radiology·2026
Same author

Survival effect of prehospital emergency anaesthesia with intubation in risk-stratified patients with major trauma: a causal modelling study.

The Lancet. Respiratory medicine·2026
Same author

Clinical evaluation of MiADE: a natural language processing system for assisting structured diagnosis recording at the point of care.

BMJ health & care informatics·2026
Same author

Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes.

BMJ open diabetes research & care·2026
Same author

Disease coverage of human genome-wide association studies and pharmaceutical research and development.

Communications medicine·2024

Related Experiment Video

Updated: Jul 13, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Artificial intelligence and machine learning for clinical pharmacology.

David K Ryan1, Rory H Maclean1,2, Alfred Balston3

  • 1Department of Clinical Pharmacology, University College London Hospitals NHS Foundation Trust, London, UK.

British Journal of Clinical Pharmacology
|October 16, 2023
PubMed
Summary

Artificial intelligence (AI) offers significant advancements in clinical pharmacology, impacting drug discovery, trials, and personalized medicine. Clinical pharmacologists must understand and rigorously evaluate AI tools for safe and equitable healthcare integration.

Keywords:
artificial intelligenceclinical pharmacologyclinical trialsmachine learningreal-world data

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

250
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.5K

Related Experiment Videos

Last Updated: Jul 13, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

250
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.5K

Area of Science:

  • Clinical pharmacology
  • Healthcare technology
  • Artificial intelligence

Background:

  • Artificial intelligence (AI) is rapidly advancing in healthcare.
  • Clinical pharmacology encompasses drug discovery, clinical trials, personalized medicine, pharmacogenomics, pharmacovigilance, and clinical toxicology.
  • Understanding AI is crucial for clinical pharmacologists.

Purpose of the Study:

  • To introduce clinical pharmacologists to AI.
  • To highlight current AI applications in clinical pharmacology.
  • To discuss AI model development, evaluation, and deployment challenges.

Main Methods:

  • Review of current AI applications in clinical pharmacology.
  • Discussion of AI model development processes.
  • Analysis of evaluation and deployment considerations for AI tools.

Main Results:

  • AI impacts numerous areas of clinical pharmacology.
  • AI tools require robust and stringent evaluation for safe and equitable enhancement of clinical practice.
  • Understanding AI empowers clinical pharmacologists to lead its integration.

Conclusions:

  • Clinical pharmacologists need to understand AI for its effective implementation.
  • Rigorous evaluation of AI tools is essential.
  • AI has the potential to transform clinical pharmacology practice safely and equitably.